Popular

• 

  RestartResume

  Digital Therapeutics Clinical Trials: From Design to Data Interpretation 

  Medical Industry Feature

  Digital Therapeutics Clinical Trials: From Design to Data Interpretation 

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Sarah Shizuko Morimoto, PsyD

    Peer

• 

  RestartResume

  Engaging Patients and Caregivers About Digital Therapeutics

  Medical Industry Feature

  Engaging Patients and Caregivers About Digital Therapeutics

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Maggie Emerson, DNP, APRN, PMHNP-BC

    Peer

• 

  RestartResume

  Evaluating First-Line Therapy for Acute
  Graft-Versus-Host Disease

  Medical Industry Feature

  Evaluating First-Line Therapy for Acute
  Graft-Versus-Host Disease

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Yi Bin Chen, MD

    Peer

  • 

    

    Olaf Penack, MD

    Peer

• 

  RestartResume

  Best Practices for an Aesthetic Neurotoxin Approach

  Medical Industry Feature

  Best Practices for an Aesthetic Neurotoxin Approach

  • 

    

    Jean Carruthers, MD

    Peer

  • 

    

    Steve Yoelin, MD

    Peer

  • 

    

    Brandice Harrison, PA-C

    Peer

• 

  RestartResume

  From Primary Care to Rheumatology: Evolving PMR Management in an Era of Innovative Treatment Options 

  Medical Industry Feature

  From Primary Care to Rheumatology: Evolving PMR Management in an Era of Innovative Treatment Options 

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Mona Amin, DO, FACR

    Peer

  • 

    

    Shital Patel, MD

    Peer

• 

  RestartResume

  Upgrade Your Adult Patients’ IgAN Treatment

  Medical Industry Feature

  Upgrade Your Adult Patients’ IgAN Treatment

  • 

    

    Abdul Abdellatif, MD, FASN

    Peer

  • 

    

    Omaima Degani, MD

    Peer

• 

  RestartResume

  Screening for Postpartum Depression: A Guideline-Based Discussion

  Medical Industry Feature

  Screening for Postpartum Depression: A Guideline-Based Discussion

  • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Jennifer L. Payne, MD

    Peer

  • 

    

    Melissa Simon, MD

    Peer

• 

  RestartResume

  Expert Insights and Clinical Strategies for Postpartum Depression Screening

  Medical Industry Feature

  Expert Insights and Clinical Strategies for Postpartum Depression Screening

  • 

    

    Jennifer L. Payne, MD

    Peer

  • 

    

    Melissa Simon, MD

    Peer

• 

  RestartResume

   Advancements in Understanding ALS Treatment

  Medical Industry Feature

   Advancements in Understanding ALS Treatment

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Gustavo Suarez Zambrano, MD

    Peer

• 

  RestartResume

  Inhibiting Inflammation in Dry Eye Disease

  Medical Industry Feature

  Inhibiting Inflammation in Dry Eye Disease

  • 

    

    Eric D. Donnenfeld, MD

    Peer

  • 

    

    Kenneth A. Beckman, MD

    Peer

  • 

    

    Preeya K. Gupta, MD

    Peer

• 

  RestartResume

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  Medical Industry Feature

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Virginia Kaklamani, MD

    Peer

  • 

    

    Anne O'Dea, MD

    Peer

• 

  RestartResume

  Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights

  Medical Industry Feature

  Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Nitasha Sarswat, MD

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

• 

  RestartResume

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  Medical Industry Feature

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

• 

  RestartResume

  The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease

  Medical Industry Feature

  The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lori Guyton, MD

    Peer

  • 

    

    Douglas Scharre, MD

    Peer

• 

  RestartResume

  Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer

  Medical Industry Feature

  Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Steven Maron, MD, MSc

    Peer